Cargando…

Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. COPD exacerbations are associated with a worsening of lung function, increased disease burden, and mortality, and, therefore, preventing their occurrence is an important goal of COPD man...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurst, John R., Han, MeiLan K., Singh, Barinder, Sharma, Sakshi, Kaur, Gagandeep, de Nigris, Enrico, Holmgren, Ulf, Siddiqui, Mohd Kashif
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396841/ https://www.ncbi.nlm.nih.gov/pubmed/35999538 http://dx.doi.org/10.1186/s12931-022-02123-5

Ejemplares similares

A Systematic Literature Review of the Humanistic Burden of COPD
por: Hurst, John R, et al.
Publicado: (2021)

Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
por: Ferguson, Gary T., et al.
Publicado: (2020)

Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis
por: Bourdin, Arnaud, et al.
Publicado: (2021)

Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study
por: de Nigris, Enrico, et al.
Publicado: (2022)

The long-term clinical impact of COPD exacerbations: a 3-year observational study (SHERLOCK)
por: Haughney, John, et al.
Publicado: (2022)

Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease
por: Albert, Richard K, et al.
Publicado: (2012)

CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Acute Exacerbations
por: Wedzicha, J.A., et al.
Publicado: (2006)

Management of Exacerbations in Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2012)

Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Hurst, John R., et al.
Publicado: (2008)

Moxifloxacin in the Outpatient Treatment of Moderate Exacerbations of Chronic Obstructive Pulmonary Disease
por: Minov, Jordan, et al.
Publicado: (2018)

Viruses and exacerbations of chronic obstructive pulmonary disease: unmet clinical need
por: Buss, L, et al.
Publicado: (2015)

Impact of bronchiectasis on the frequency and severity of respiratory exacerbations in COPD
por: Labaki, Wassim W, et al.
Publicado: (2018)

25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease
por: Quint, Jennifer K, et al.
Publicado: (2012)

Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy
por: Han, MeiLan K
Publicado: (2020)

From Conundrum to Cures, Pioneering Breakthroughs in Chronic Obstructive Pulmonary Disease Research: Introduction to an AJRCCM Special Issue
por: Han, MeiLan K.
Publicado: (2023)

Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review
por: Hurst, John R, et al.
Publicado: (2009)

Bacterial etiology and pneumococcal urinary antigen in moderate exacerbation of chronic obstructive pulmonary disease
por: Yoo, Jungmin, et al.
Publicado: (2022)

Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease
por: Hernández Cordero, Ana I., et al.
Publicado: (2021)

Subtypes of Patients with Mild to Moderate Airflow Limitation as Predictors of Chronic Obstructive Pulmonary Disease Exacerbation
por: Kim, Nam Eun, et al.
Publicado: (2023)

Prognostic Usefulness of Basic Analytical Data in Chronic Obstructive Pulmonary Disease Exacerbation
por: Martínez-Gestoso, Sandra, et al.
Publicado: (2023)

Unmet needs in the management of exacerbations of chronic obstructive pulmonary disease
por: Waeijen-Smit, Kiki, et al.
Publicado: (2021)

Monitoring of Physiological Parameters to Predict Exacerbations of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review
por: Al Rajeh, Ahmed M., et al.
Publicado: (2016)

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
por: Whittaker, Hannah, et al.
Publicado: (2022)

Thoracic Imaging at Exacerbation of Chronic Obstructive Pulmonary Disease: A Systematic Review
por: Rangelov, Bojidar A, et al.
Publicado: (2020)

Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?
por: Wang, Jennifer M., et al.
Publicado: (2022)

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
por: Duffy, Sean, et al.
Publicado: (2017)

Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study
por: Hurst, John R, et al.
Publicado: (2010)

Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction
por: Jo, Yong Suk, et al.
Publicado: (2018)

Reply to Wang and Lai: The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Han, MeiLan K., et al.
Publicado: (2021)

Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood
por: Freeman, Christine M., et al.
Publicado: (2015)

Exacerbations of Chronic Obstructive Pulmonary Disease
por: Garvey, Christine, et al.
Publicado: (2012)

The Chronic Obstructive Pulmonary Disease Exacerbation
por: Sherk, Peter A., et al.
Publicado: (2000)

Exacerbation of Chronic Obstructive Pulmonary Disease
por: Zhou, Xianghui, et al.
Publicado: (2015)

Time‐Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial
por: Dransfield, Mark T., et al.
Publicado: (2022)

InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations
por: Singh, Dave, et al.
Publicado: (2021)

Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study
por: Rhodes, Kirsty, et al.
Publicado: (2022)

Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
por: Dreyse, Jorge, et al.
Publicado: (2015)

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD
por: Wilson, Robert, et al.
Publicado: (2015)

The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model
por: Sadatsafavi, Mohsen, et al.
Publicado: (2016)

Reply to López-Campos et al.: Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
por: Lipson, David A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cs7nfsktvt7bal706b91fsdtl1